Pharmaceutical company accelerates product launch readiness with KoLab

Like most pharma teams, a top pharmaceutical company relied heavily on traditional advisory boards — in-person gatherings of healthcare providers to gather strategic insight before and after product launches. These sessions were valuable, but they had limits: constrained by scheduling, travel logistics, and cost, the team had narrow windows to engage their advisors and act on what they heard.

With rapidly approaching milestones, they required a faster, more flexible approach to continuous HCP engagement. Specifically, this pharma company wanted their advisors to be among the first to see both HCP- and patient-facing materials — using the opportunity to gather candid early feedback and surface unmet educational needs in the therapeutic area. The question wasn't whether their advisors had valuable perspectives. It was whether the traditional format could unlock them quickly enough.

This company ran their first KeyOps KoLab session — a cross-functional engagement designed to gather HCP feedback on external materials before the new year. The objective: validate materials and messaging that had been developed but never tested with physicians. The KeyOps team onboarded HCPs onto the KoLab platform, providing participants a two-week window to annotate materials, answer survey questions, and provide commentary on their own schedule.

This team plans to use KeyOps to continuously gather insights from physicians throughout the different stages of the product lifecycle. The goal: a living pulse on HCP sentiment and experience — not just a snapshot once or twice a year.